Global Rheumatoid Arthritis Partnering 2012 to 2018 Market Report; Launched via MarketResearchReports.com
MarketResearchReprots.com has announced the addition of “Global Rheumatoid Arthritis Partnering 2012 to 2018” research report to their website www.MarketResearchReports.com
Lewes, DE -- (SBWire) -- 12/12/2018 --Provides understanding and access to the rheumatoid partnering deals and agreements entered into by the worlds leading healthcare companies.
The Global Rheumatoid Arthritis Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.
- Trends in partnering deals
- Top deals by value
- Deals listed by company A-Z, industry sector, stage of development, technology type
The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare companies.
The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.
This data driven report contains multiple links to online copies of actual deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
The initial chapters of this report provide an orientation of partnering trends.
Chapter 1 provides an overview of the trends in partnering since 2012, including a summary of deals by industry sector, stage of development, deal type, and technology type.
Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.
Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2012. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.
Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.
Chapters 5 and 6 provide a summary of M&A deals since 2012 where the acquired company is active in the therapy area of interest.
Chapters 7 and 8 provide a summary of financings since 2012 where the financed company is active in the therapy area of interest.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.
Global Rheumatoid Arthritis Partnering Terms and Agreements since 2012 report provides the reader with the following key benefits:
- In-depth understanding of deal trends since 2012
- Access to headline, upfront, milestone and royalty data
- Comprehensive access to multiple deals entered into by the world's biopharma companies since 2012
- Insight into key deal terms included in contracts, where disclosed
- Understand the key deal terms companies have agreed in deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Spanning over 200 pages "Global Rheumatoid Arthritis Partnering 2012 to 2018" report covers Executive Summary, Therapypartnering trends in numbers, Most active dealmakers, Partnering deals directory, Partnering deals with a contract document.
Please visit this link for more details: https://www.marketresearchreports.com/current-partnering/global-rheumatoid-arthritis-partnering-2012-2018
Find all Drug Pipeline Reports at: https://www.marketresearchreports.com/drug-pipeline
For related reports please visit: https://www.marketresearchreports.com/search/site/Rheumatoid%2520Arthritis
Read our Interactive Market Research Blog
MarketResearchReprots.com is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.
Contact us for your market research requirements: https://www.marketresearchreports.com/contact
Media Relations Contact
Director - Operations
View this press release online at: http://rwire.com/1102404